Literature DB >> 31782054

The societal monetary value of a QALY associated with EQ-5D-3L health gains.

Laura Vallejo-Torres1,2,3, Borja García-Lorenzo4,5, Oliver Rivero-Arias4,6,7, José Luis Pinto-Prades8.   

Abstract

There is an extensive body of empirical research that focuses on the societal monetary value of a quality-adjusted life year (MVQALY). Many of these studies have found the estimates to be inversely associated with the size of the health gain, and thus not conforming to the linearity assumption imposed in the QALY model. In this study, we explore the extent to which the MVQALY varies when it is associated with different types and magnitudes of quality of life (QoL) improvements. To allow for a comprehensive assessment, we derive the MVQALY corresponding to the full spectrum of health gains defined by the EQ-5D-3L instrument. The analysis was based on a large and representative sample of the population in Spain. A discrete choice experiment and a time trade-off exercise were used to derive a value set for utilities, followed by a willingness to pay questionnaire. The data were jointly analysed using regression analyses and bootstrapping techniques. Our findings indicate that societal values for a QALY corresponding to different EQ-5D-3L health gains vary approximately between 10,000€ and 30,000€. MVQALY associated with larger improvements on QoL was found to be lower than that associated with moderate QoL gains. The potential sources of the observed non-constant MVQALY are discussed.

Keywords:  EQ-5D; Quality-adjusted life year; Social perspective; Willingness to pay

Year:  2019        PMID: 31782054     DOI: 10.1007/s10198-019-01140-4

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  24 in total

1.  Using a discrete choice experiment to estimate health state utility values.

Authors:  Nick Bansback; John Brazier; Aki Tsuchiya; Aslam Anis
Journal:  J Health Econ       Date:  2011-12-06       Impact factor: 3.883

2.  GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.

Authors:  Ana Bobinac; N Job A van Exel; Frans F H Rutten; Werner B F Brouwer
Journal:  J Health Econ       Date:  2011-10-01       Impact factor: 3.883

3.  Scope insensitivity in contingent valuation of complex environmental amenities.

Authors:  Knut Veisten; Hans Fredrik Hoen; Ståle Navrud; Jon Strand
Journal:  J Environ Manage       Date:  2004-12       Impact factor: 6.789

4.  Estimating a WTP-based value of a QALY: the 'chained' approach.

Authors:  Angela Robinson; Dorte Gyrd-Hansen; Philomena Bacon; Rachel Baker; Mark Pennington; Cam Donaldson
Journal:  Soc Sci Med       Date:  2013-06-04       Impact factor: 4.634

5.  Valuing SF-6D Health States Using a Discrete Choice Experiment.

Authors:  Richard Norman; Rosalie Viney; John Brazier; Leonie Burgess; Paula Cronin; Madeleine King; Julie Ratcliffe; Deborah Street
Journal:  Med Decis Making       Date:  2013-09-11       Impact factor: 2.583

Review 6.  On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?

Authors:  Laura Vallejo-Torres; Borja García-Lorenzo; Iván Castilla; Cristina Valcárcel-Nazco; Lidia García-Pérez; Renata Linertová; Elena Polentinos-Castro; Pedro Serrano-Aguilar
Journal:  Value Health       Date:  2016-04-23       Impact factor: 5.725

7.  Beyond QALYs: Multi-criteria based estimation of maximum willingness to pay for health technologies.

Authors:  Erik Nord
Journal:  Eur J Health Econ       Date:  2017-03-03

8.  Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach.

Authors:  Juan M Ramos-Goñi; Benjamin M Craig; Mark Oppe; Yolanda Ramallo-Fariña; Jose Luis Pinto-Prades; Nan Luo; Oliver Rivero-Arias
Journal:  Value Health       Date:  2017-12-02       Impact factor: 5.725

9.  Testing a discrete choice experiment including duration to value health states for large descriptive systems: addressing design and sampling issues.

Authors:  Nick Bansback; Arne Risa Hole; Brendan Mulhern; Aki Tsuchiya
Journal:  Soc Sci Med       Date:  2014-05-20       Impact factor: 4.634

10.  Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach.

Authors:  Juan M Ramos-Goñi; Jose L Pinto-Prades; Mark Oppe; Juan M Cabasés; Pedro Serrano-Aguilar; Oliver Rivero-Arias
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

View more
  2 in total

1.  Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression.

Authors:  Christian R C Kouakou; Thomas G Poder
Journal:  Eur J Health Econ       Date:  2021-08-21

2.  Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain.

Authors:  Maria Mareque; Pau Montesinos; Patricia Font; José María Guinea; Adolfo de la Fuente; Javier Soto; Itziar Oyagüez; James Brockbank; Tamara Iglesias; Julia Llinares; Jorge Sierra
Journal:  Clinicoecon Outcomes Res       Date:  2021-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.